Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial

BACKGROUND: The objective was to evaluate the safety and immunogenicity of the AMA1-based malaria vaccine FMP2.1/AS02(A) in children exposed to seasonal falciparum malaria. METHODOLOGY/PRINCIPAL FINDINGS: A Phase 1 double blind randomized controlled dose escalation trial was conducted in Bandiagara,...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Thera, Mahamadou A., Doumbo, Ogobara K., Coulibaly, Drissa, Laurens, Matthew B., Kone, Abdoulaye K., Guindo, Ando B., Traore, Karim, Sissoko, Mady, Diallo, Dapa A., Diarra, Issa, Kouriba, Bourema, Daou, Modibo, Dolo, Amagana, Baby, Mounirou, Sissoko, Mahamadou S., Sagara, Issaka, Niangaly, Amadou, Traore, Idrissa, Olotu, Ally, Godeaux, Olivier, Leach, Amanda, Dubois, Marie-Claude, Ballou, W. Ripley, Cohen, Joe, Thompson, Darby, Dube, Tina, Soisson, Lorraine, Diggs, Carter L., Takala, Shannon L., Lyke, Kirsten E., House, Brent, Lanar, David E., Dutta, Sheetij, Heppner, D. Gray, Plowe, Christopher V.
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2010
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2816207/
https://ncbi.nlm.nih.gov/pubmed/20140214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0009041
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים